Related Experiment Video
Updated: Aug 7, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Genetic Architecture of Familial Hypercholesterolaemia
Mahtab Sharifi1,2, Marta Futema1, Devaki Nair2
1Institute of Cardiovascular Science, University College London, 5 University St, London, WC1E 6JF, UK.
Insights
Familial hypercholesterolaemia (FH) is an inherited cholesterol disorder. Genetic factors influence its cardiovascular risks and management, with new sequencing methods improving understanding.
Area of Science:
- Genetics
- Cardiology
- Biochemistry
Background:
- Familial hypercholesterolaemia (FH) is an inherited disorder characterized by elevated low-density lipoprotein cholesterol (LDL-C) levels from birth.
- It significantly increases the risk of premature coronary heart disease.
- Understanding the genetic basis is crucial for diagnosis and management.
Purpose of the Study:
- To review the genetic underpinnings of Familial hypercholesterolaemia.
- To explore the impact of genetic factors on the clinical presentation of FH.
- To discuss advancements in understanding FH genetics.
Main Methods:
- Review of existing literature on FH genetics.
- Analysis of genetic mutations (LDLR, APOB, PCSK9) and polygenic factors.
- Discussion of emerging genotyping technologies like next-generation sequencing.
Main Results:
- Mutations in LDLR, APOB, or PCSK9 genes cause FH in approximately 40% of clinically diagnosed patients.
- A polygenic aetiology, involving common LDL-C-raising variants, is likely in the remaining cases.
- Genetic factors influence cardiovascular presentation and management strategies.
Conclusions:
- The genetic architecture of FH is complex, involving both monogenic and polygenic factors.
- Next-generation sequencing promises a deeper understanding of FH's genetic basis.
- Personalized approaches to FH management may arise from improved genetic insights.
Purpose Of Review:
Familial hypercholesterolaemia (FH) is an inherited disorder of low-density lipoprotein cholesterol (LDL-C) which is characterised by a raised cholesterol level from birth and a high risk of premature coronary heart disease. In this paper, we review the genetic basis of FH and its impact on the clinical presentation.
Recent Findings:
Mutations in any of three genes (LDLR, APOB and PCSK9) are known to cause autosomal dominant FH, but a mutation can be found in only ∼40% of patients with a clinical diagnosis of FH. In the remainder, a polygenic aetiology is most likely, due to the co-inheritance of common LDL-C-raising variants. The cardiovascular presentation and management of FH will differ between patients based on their underlying genetic factors. New genotyping methods such as next-generation sequencing will provide us with better understanding of the genetic architecture of FH.
More Related Videos
Related Concept Videos
Genetic Lingo
Pleiotropy
Inheritance of Chromatin Structures
Cholesterol: Significance and Regulation
Considering cholesterol and...
Pharmacogenomics: Identification of New Drug Targets
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

